1-20 of 187
Mazyar Shadman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis.

Available to Purchase
Miguel-Angel Perales, Farrukh T Awan, Ariane Boumendil, Jinalben Patel, Luca Castagna, Emanuele Angelucci, Herve Finel, Alexander D. Kulagin, Bertram Glass, Paolo Corradini, Alex F. Herrera, Didier Blaise, Mohamed A Kharfan-Dabaja, Khalid Halahleh, Sairah Ahmed, Carmen Martinez, Sebastian Giebel, Silvia Montoto, Richard J. Jones, Nausheen Ahmed, Ryan C Lynch, Marcos J de Lima, Mazyar Shadman, Craig S. Sauter, Kwang Woo Ahn, Mehdi Hamadani, Ali Bazarbachi, Anna Sureda
Journal: Blood
Blood blood.2024027197.
https://doi.org/10.1182/blood.2024027197
Published: 2025
Includes: Supplemental data
Journal Articles

Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma

Available to Purchase
Clinical Trials & Observations Brief Report
Laura Samples, Hossein Sadrzadeh, Matthew J. Frigault, Caron A. Jacobson, Mehdi Hamadani, Ashwath Gurumurthi, Paolo Strati, Roni Shouval, Ariela Noy, Peter A. Riedell, Saurabh Dahiya, David G. Maloney, Brian G. Till, Alexandre V. Hirayama, Jordan Gauthier, Ajay K. Gopal, Stephen D. Smith, Christina Poh, Ryan Lynch, Chaitra Ujjani, Mengyang Di, Vikram Raghunathan, Mehrdad Shakib-Azar, Kikkeri N. Naresh, Ted A. Gooley, Jean Yared, Michael D. Jain, Frederick L. Locke, Lori Ann Leslie, Narendranath Epperla, Monalisa Ghosh, Alan Skarbnik, Brian T. Hill, Manali K. Kamdar, Valentin Ortiz-Maldonado, Nuria Martinez-Cibrian, Leyla Shune, Mazyar Shadman
Journal: Blood
Blood (2025) 145 (23): 2762–2767.
https://doi.org/10.1182/blood.2024026831
Published: 2025
Includes: Supplemental data
Journal Articles

A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up

Available to Purchase
Clinical Trials & Observations
Sherilyn A Tuazon, Andrew J. Portuguese, Margot J Pont, Andrew J Cowan, Gabriel O Cole, Blythe D Sather, Xiaoling Song, Sushma Thomas, Brent L. Wood, Michelle Lee Blake, Melissa G Works, Mazyar Shadman, Emily C. Liang, Qian Wu, Jenna M Voutsinas, Ted A Gooley, Cameron J Turtle, Brian G. Till, David G Coffey, David G Maloney, Stanley R. Riddell, Damian J Green
Journal: Blood
Blood blood.2024027681.
https://doi.org/10.1182/blood.2024027681
Published: 2025
Includes: Supplemental data
Journal Articles

Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies

Open Access
Clinical Trials & Observations
Laurie H. Sehn, Nancy L. Bartlett, Matthew J. Matasar, Stephen J. Schuster, Sarit E. Assouline, Pratyush Giri, John Kuruvilla, Mazyar Shadman, Chan Yoon Cheah, Sascha Dietrich, Keith Fay, Matthew Ku, Loretta J. Nastoupil, Michael C. Wei, Shen Yin, Iris To, Derrick Kaufman, Antonia Kwan, Elicia Penuel, Christopher R. Bolen, Lihua E. Budde
Journal: Blood
Blood (2025) 145 (7): 708–719.
https://doi.org/10.1182/blood.2024025454
Published: 2025
Includes: Supplemental data
Journal Articles

Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE

Free
Clinical Trials & Observations
Jennifer R. Brown, Barbara Eichhorst, Nicole Lamanna, Susan M. O’Brien, Constantine S. Tam, Lugui Qiu, Wojciech Jurczak, Keshu Zhou, Martin Šimkovič, Jiří Mayer, Amanda Gillespie-Twardy, Alessandra Ferrajoli, Peter S. Ganly, Robert Weinkove, Sebastian Grosicki, Andrzej Mital, Tadeusz Robak, Anders Osterborg, Habte A. Yimer, Megan Wang, Tommi Salmi, Liping Wang, Jessica Li, Kenneth Wu, Aileen Cohen, Mazyar Shadman
Journal: Blood
Blood (2024) 144 (26): 2706–2717.
https://doi.org/10.1182/blood.2024024667
Published: 2024
Includes: Supplemental data
Journal Articles

Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell Lymphoma: A Single-Center Retrospective Analysis

Free
Carrie I Ho, Neena Kennedy, Mengyang Di, Ajay K. Gopal, Ryan C Lynch, Christina Poh, Vikram Raghunathan, Heather Rasmussen, Mazyar Shadman, Brian G. Till, Chaitra S. Ujjani, Stephen D. Smith
Journal: Blood
Blood (2024) 144 (Supplement 1): 783.
https://doi.org/10.1182/blood-2024-208269
Published: 2024
Journal Articles

Epcoritamab Monotherapy in Patients (Pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from CLL Expansion and Optimization Cohorts of Epcore CLL-1

Free
Alexey Danilov, Bita Fakhri, Farrukh T. Awan, Hans Herluf Bentzen, Herbert A. Eradat, Carsten Utoft Niemann, Fritz Offner, Christian Bjørn Poulsen, Thor Hoeyer, Mar Bellido, Damien Roos Weil, Alessandra Ferrajoli, Meghan C. Thompson, Jacob Haaber Christensen, Ann Janssens, Tamar Tadmor, Mazyar Shadman, Pegah Jafarinasabian, Jimin Zhang, Marcia Rios, Alexandra Kuznetsova, Rebecca Valentin, Arnon P. Kater
Journal: Blood
Blood (2024) 144 (Supplement 1): 883.
https://doi.org/10.1182/blood-2024-199708
Published: 2024
Journal Articles

Pralatrexate Is Effective in Cytotoxic Cutaneous T-Cell Lymphomas

Free
Christina Poh, Jenna M. Voutsinas, Ivan Huang, Edus H. Warren, Caitlin A. Crimp, Mazyar Shadman, Ryan C. Lynch, Brian G. Till, Chaitra S. Ujjani, Mengyang Di, Vikram Raghunathan, Stephen D. Smith, Qian Vicky Wu, Michi M. Shinohara, Ajay K. Gopal
Journal: Blood
Blood (2024) 144 (Supplement 1): 1684.
https://doi.org/10.1182/blood-2024-194018
Published: 2024
Journal Articles

Real-World (RW) Outcomes of Lisocabtagene Maraleucel (liso-cel) As Second-Line (2L) Therapy in Patients (pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): First Results from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry

Free
Maria Silvina Odstrcil Bobillo, Swetha Kambhampati, Dasom Lee, Bradley D. Hunter, Ogechukwu Egini, Krish Patel, Patrick M. Reagan, David Bernasconi, Soyoung Kim, Charimar Santiago Parrilla, Tracy Krimmel, Fei Fei Liu, Debasmita Roy, Sairah Ahmed, Jennifer L. Crombie, Saurabh Dahiya, Mehdi Hamadani, Catherine J. Lee, Marcelo C. Pasquini, Mazyar Shadman, Alex F. Herrera, Matthew Frigault
Journal: Blood
Blood (2024) 144 (Supplement 1): 470.
https://doi.org/10.1182/blood-2024-199723
Published: 2024
Journal Articles

Sustained Superiority of Zanubrutinib vs Bendamustine + Rituximab in Treatment-Naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (TN CLL): 5-Year Follow-Up of Cohort 1 from the SEQUOIA Study

Free
Mazyar Shadman, Talha Munir, Tadeusz Robak, Jennifer R. Brown, Brad S. Kahl, Paolo Ghia, Tian Tian, Andy Szeto, Roman Korolkiewicz, Constantine S. Tam, Wojciech Jurczak
Journal: Blood
Blood (2024) 144 (Supplement 1): 3249.
https://doi.org/10.1182/blood-2024-194864
Published: 2024
Journal Articles

Impact of Immunophenotype on Clinical Disease Characteristics and Outcomes in T-Cell Prolymphocytic Leukemia

Free
Christina Poh, Xueyan Chen, Jenna M. Voutsinas, Edus H. Warren, Mazyar Shadman, Ryan C. Lynch, Brian G. Till, Chaitra S. Ujjani, Mengyang Di, Vikram Raghunathan, Stephen D. Smith, Qian Vicky Wu, Sindhu Cherian, Ajay K. Gopal
Journal: Blood
Blood (2024) 144 (Supplement 1): 3069.
https://doi.org/10.1182/blood-2024-205892
Published: 2024
Journal Articles

Five-Year Survival of Patients (pts) from Transcend NHL 001 (TRANSCEND) Supports Curative Potential of Lisocabtagene Maraleucel (liso-cel) in Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Free
Jeremy S. Abramson, Maria Lia Palomba, Leo I. Gordon, Matthew Lunning, Michael Wang, Jon E. Arnason, Manali Kamdar, David G. Maloney, Mazyar Shadman, Charalambos Andreadis, Alison R. Sehgal, Scott R. Solomon, Nilanjan Ghosh, Juliana E. Hidalgo-López, Jing Wang, Ken Ogasawara, Ashvin Singh, Tanya Siddiqi
Journal: Blood
Blood (2024) 144 (Supplement 1): 3125.
https://doi.org/10.1182/blood-2024-200204
Published: 2024
Journal Articles

Evaluation of Outcomes and Toxicities of Commercial Axicabtagene Ciloleucel (axi-cel) and Tisagenlecleucel (tisa-cel) for Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Real-World Evidence (RWE) from 10 US Academic Centers

Free
John Sharp, Paolo Strati, Subodh Bhatta, Jennifer J. Huang, Colin Thomas, Daniel K Reef, Alexander Gorzewski, Catherine Reinert, Andinet Teferra, Ari Pelcovits, Thomas Ollila, Joseph E. Maakaron, Manali K. Kamdar, Lindsey Fitzgerald, Reem Karmali, Natalie Grover, Stefan K. Barta, Timothy Voorhees, Mazyar Shadman, Sairah Ahmed, Narendranath Epperla
Journal: Blood
Blood (2024) 144 (Supplement 1): 2377.
https://doi.org/10.1182/blood-2024-203753
Published: 2024
Journal Articles

Real-World Early Outcomes of Second-Line Axicabtagene Ciloleucel (Axi-Cel) Therapy in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Free
Dasom (Caroline) Lee, Swetha Kambhampati, Maria Silvina Odstrcil Bobillo, Babatunde Adedokun, Mazyar Shadman, Amanda L. Olson, Alex F. Herrera, Catherine J. Lee, Caron A. Jacobson, Matthew Bye, Mehdi Hamadani, Soyoung Kim, Saurabh Dahiya, Zhen-Huan Hu, Kelly Speth, Christina To, Debbie L. Mirjah, Timothy Best, Frederick L. Locke, Nausheen Ahmed, Michael T. Tees, Marcelo C. Pasquini, Sairah Ahmed
Journal: Blood
Blood (2024) 144 (Supplement 1): 526.
https://doi.org/10.1182/blood-2024-199139
Published: 2024
Journal Articles

Circulating Tumor DNA (ctDNA) As an Early Outcome Predictor in Patients (pts) with Second-Line (2L) Large B-Cell Lymphoma (LBCL) after Lisocabtagene Maraleucel (liso-cel) Versus Standard of Care (SOC) Treatment (tx) from the Phase 3, Randomized Transform Study

Free
Lara Stepan, Sahar Ansari, Abood Okal, Justine Dell'Aringa, Ethan G. Thompson, Alessandro Crotta, Victor A. Chow, Jeremy S. Abramson, Manali Kamdar, Scott R. Solomon, Patrick B. Johnston, Bertram Glass, Pim Mutsaers, Jon E. Arnason, Stephan Mielke, Mazyar Shadman, Francisco Hernandez-Ilizaliturri, Koji Izutsu, Veronika Bachanova, Sami Ibrahimi, Jacob Chabon, David Kurtz, Ash A. Alizadeh, Leanne Peiser
Journal: Blood
Blood (2024) 144 (Supplement 1): 72.
https://doi.org/10.1182/blood-2024-199813
Published: 2024
Journal Articles

Mosunetuzumab Continues to Demonstrate Clinically Meaningful Outcomes in Patients with Relapsed and/or Refractory Follicular Lymphoma after ≥2 Prior Therapies Including Those with a History of POD24: 4-Year Follow-up of a Pivotal Phase II Study

Free
Mazyar Shadman, Nancy L. Bartlett, Matthew Matasar, Stephen J. Schuster, Sarit E. Assouline, Laurie H. Sehn, John Kuruvilla, Pratyush Giri, Chan Y. Cheah, Sascha Dietrich, Keith Fay, Matthew Ku, Loretta Nastoupil, Michael C. Wei, Shen Yin, Connie Y. Ma, Samuel Tracy, Antonia Kwan, Elicia Penuel, L. Elizabeth Budde
Journal: Blood
Blood (2024) 144 (Supplement 1): 4407.
https://doi.org/10.1182/blood-2024-197897
Published: 2024
Journal Articles

Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin (P-GVD) for Classical Hodgkin Lymphoma (CHL) in the Real-World Setting

Free
Grace T. Baek, Gaurav Varma, Samuel Yamshon, Herman van Besien, Nancy L. Bartlett, Marcus P. Watkins, Harsh R. Shah, Kelsey Baron, Reid W. Merryman, Ayo S Falade, Jakub Svoboda, Sara Prischak, Christopher R D'Angelo, Joe D. Lukowski, Ranjana H. Advani, Austin H. Yeung, Maya C. Rosenberg, Jenna M. Voutsinas, Mengyang Di, Ryan C Lynch, Christina Poh, Vikram Raghunathan, Mazyar Shadman, Stephen D. Smith, Brian G. Till, Chaitra S. Ujjani, Catherine S. Diefenbach, Ajay K. Gopal
Journal: Blood
Blood (2024) 144 (Supplement 1): 4431.
https://doi.org/10.1182/blood-2024-200719
Published: 2024
Journal Articles

Real-World Treatment Patterns and Clinical Outcomes Among Patients with Diffuse Large B-Cell Lymphoma in a US Healthcare Claims Database

Free
Mazyar Shadman, Jennifer S. Harper, Alex Bokun, Gloria HJ Graf, Xiaoxiao Lu
Journal: Blood
Blood (2024) 144 (Supplement 1): 2362.
https://doi.org/10.1182/blood-2024-203289
Published: 2024
Journal Articles

Dose-Dense Brentuximab Vedotin Plus Ifosfamide, Carboplatin, and Etoposide (ICE) in Second Line Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma: 5-Year Long Term Follow up

Free
Ryan C. Lynch, Ryan D. Cassaday, Stephen D. Smith, Andrew J. Cowan, Edus H. Warren, Mazyar Shadman, Brian G. Till, Chaitra S. Ujjani, Karolyn Morris, Heather Rasmussen, Jenna M. Voutsinas, Ajay K. Gopal
Journal: Blood
Blood (2024) 144 (Supplement 1): 3043.
https://doi.org/10.1182/blood-2024-206047
Published: 2024
Journal Articles

Association Between Dose Reduction and Duration of Therapy in Patients Receiving Ibrutinib or Acalabrutinib for Chronic Lymphocytic Leukemia: A Medical Chart Review Study

Free
Mazyar Shadman, Lindsey Roeker, Javier Pinilla-Ibarz, Bhavini Srivastava, Sudeep Karve, Gabriel S. Krigsfeld, Erin Franceschini, Chadi Saifan, Siddharth Karanth, Ravi K. Goyal, Julien Rombi, Deborah M. Stephens
Journal: Blood
Blood (2024) 144 (Supplement 1): 3742.
https://doi.org/10.1182/blood-2024-205456
Published: 2024